Heterochromatin on the human inactive X chromosome

人类失活 X 染色体上的异染色质

基本信息

  • 批准号:
    8135311
  • 负责人:
  • 金额:
    $ 30.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-02-01 至 2013-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): X chromosome inactivation is an essential mammalian epigenetic process that serves to balance the levels of X-linked gene expression between the sexes. The inactive X chromosome (Xi) is the most extensive example of developmentally regulated gene silencing, and provides a model to explore in depth the epigenetic features of heterochromatin and to relate these to the underlying genomic DNA sequence. Unexpectedly, the X-linked macrosatellite DXZ4 is packaged into the opposite chromatin arrangement than that of the surrounding chromosome. Consequently, DXZ4 on the Xi is organized into euchromatin, whereas the array on the active X chromosome (Xa) is heterochromatic. DXZ4 is bi-directionally transcribed on both the Xa and Xi, but the processing of the non-coding RNAs differs between the two chromosomes. Cleavage of the antisense transcript into small RNAs coincides with the heterochromatic form of DXZ4, and the small RNAs themselves directly align with nucleosomes bearing the heterochromatin modification H3K9me3. Meanwhile, antisense RNA originating from the Xi is sufficiently stable that it can be detected as a longer transcript. Intriguingly, the chromatin insulator and epigenetic organizer protein CTCF binds specifically to the Xi array, immediately adjacent to the DXZ4 bi-directional promoter. To what extent CTCF is involved in establishing and maintaining DXZ4 chromatin on the Xi, and the impact this unusual organization has on flanking chromatin is unknown. However, the contrasting arrangement of DXZ4 chromatin between the X chromosomes and the specific binding of CTCF to the Xi is conserved at the functional homologue of DXZ4 on the mouse X chromosome (Dxz4), suggesting that this organization serves an important function. Our long-term goal is to understand the role of DXZ4 on the Xa and Xi and the extent to which it is involved in organizing and maintaining flanking chromatin and gene expression. We hypothesize that (A) The Xa processed antisense small RNAs are intimately linked to H3K9me3, via a mammalian pathway similar to RNAi mediated heterochromatin formation described for S.pombe, and (B) The Xi specific association of CTCF with DXZ4 ensures stabilization of antisense transcripts, packaging of the array into euchromatin and maintenance of flanking heterochromatin. In order to test these hypotheses, we propose three specific aims: (i) To define in detail the chromatin organization of DXZ4/Dxz4 on the Xa and Xi, (ii) To understand the role of DXZ4 features in maintaining chromatin and expression of both the array and flanking genomic interval on the Xa and Xi and (iii) To assess the role of Dxz4 on the mouse X. Taken together, these studies are designed to explore the mechanisms that direct packaging of DNA into euchromatin and heterochromatin and will provide valuable insight into the role of RNA in chromatin organization in complex genomes. As such, this research has direct relevance to all forms of epigenetic abnormalities including imprinting disorders, genetic disease involving mutation of chromatin proteins, and the many chromatin alterations observed in cancer. PUBLIC HEALTH RELEVANCE: The proposed studies aim to investigate an unusual epigenetic phenomena involving the macrosatellite sequence DXZ4 on the inactive X chromosome. DXZ4 is a paradigm to explore in depth the interplay between epigenetic features in establishing and maintaining chromatin organization. Therefore, this research has direct relevance to all forms of epigenetic abnormalities including imprinting disorders such as Prader-Willi/Angleman syndrome or Beckwith-Weidemann syndrome, genetic disease involving mutation of chromatin proteins such as Rett syndrome, and the many chromatin changes observed in cancer. Furthermore, understanding the packaging and organization of DXZ4 will have direct impact on Facioscapulohumeral Muscular Dystrophy research, a devastating macrosatellite contraction disorder.
描述(由申请人提供):X染色体失活是哺乳动物表观遗传学的一个重要过程,用于平衡性别间X连锁基因表达水平。失活的X染色体(Xi)是发育调控基因沉默的最广泛的例子,并提供了一个模型,以深入探讨异染色质的表观遗传特征,并将这些与潜在的基因组DNA序列。出乎意料的是,X连锁的大卫星DXZ 4被包装成与周围染色体相反的染色质排列。因此,Xi上的DXZ 4被组织成常染色质,而活性X染色体(Xa)上的阵列是异染色质。DXZ 4在Xa和Xi上双向转录,但两条染色体之间非编码RNA的加工不同。反义转录物切割成小RNA与DXZ 4的异染色质形式一致,并且小RNA本身直接与带有异染色质修饰H3 K9 me 3的核小体对齐。同时,源自Xi的反义RNA是足够稳定的,其可以作为更长的转录物被检测到。有趣的是,染色质绝缘体和表观遗传组织者蛋白CTCF特异性结合到Xi阵列,紧邻DXZ 4双向启动子。CTCF在多大程度上参与了Xi上DXZ 4染色质的建立和维持,以及这种不寻常的组织对侧翼染色质的影响尚不清楚。然而,DXZ 4染色质在X染色体之间的对比排列和CTCF与Xi的特异性结合在小鼠X染色体上DXZ 4的功能同源物(Dxz 4)处是保守的,这表明这种组织具有重要的功能。我们的长期目标是了解DXZ 4在Xa和Xi上的作用,以及它参与组织和维持侧翼染色质和基因表达的程度。我们假设(A)Xa加工的反义小RNA通过类似于针对粟酒裂殖酵母所述的RNAi介导的异染色质形成的哺乳动物途径与H3 K9 me 3紧密连接,以及(B)CTCF与DXZ 4的Xi特异性缔合确保反义转录物的稳定、阵列包装到常染色质中以及侧翼异染色质的维持。为了验证这些假设,我们提出了三个具体目标:(i)详细定义DXZ 4/Dxz 4在Xa和Xi上的染色质组织,(ii)了解DXZ 4特征在维持染色质和Xa和Xi上的阵列和侧翼基因组间隔表达中的作用,以及(iii)评估Dxz 4在小鼠X染色体上的作用。总之,这些研究旨在探索DNA直接包装成常染色质和异染色质的机制,并将为RNA在复杂基因组中染色质组织中的作用提供有价值的见解。因此,这项研究与所有形式的表观遗传异常直接相关,包括印记疾病,涉及染色质蛋白突变的遗传疾病,以及在癌症中观察到的许多染色质改变。公共卫生相关性:这项研究旨在研究一种不寻常的表观遗传现象,涉及非活性X染色体上的大卫星序列DXZ 4。DXZ 4是深入探索表观遗传特征在建立和维持染色质组织中的相互作用的范例。因此,这项研究与所有形式的表观遗传异常直接相关,包括印记疾病,如Prader-Willi/Angleman综合征或Beckwith-Weidemann综合征,涉及染色质蛋白突变的遗传疾病,如Rett综合征,以及在癌症中观察到的许多染色质变化。此外,了解DXZ 4的包装和组织将直接影响面肩肱肌营养不良症的研究,这是一种毁灭性的大卫星收缩疾病。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Brian P. Chadwick其他文献

Macrosatellite epigenetics: the two faces of DXZ4 and D4Z4
  • DOI:
    10.1007/s00412-009-0233-5
  • 发表时间:
    2009-08-19
  • 期刊:
  • 影响因子:
    2.300
  • 作者:
    Brian P. Chadwick
  • 通讯作者:
    Brian P. Chadwick

Brian P. Chadwick的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Brian P. Chadwick', 18)}}的其他基金

Exploring the contribution of large tandem repeat DNA to the organization and maintenance of the inactive X chromosome
探索大串联重复 DNA 对失活 X 染色体的组织和维护的贡献
  • 批准号:
    9324288
  • 财政年份:
    2016
  • 资助金额:
    $ 30.8万
  • 项目类别:
Developing resources to alleviate muscle atrophy in FSHD by genome engineering
通过基因组工程开发资源缓解 FSHD 肌肉萎缩
  • 批准号:
    8414059
  • 财政年份:
    2012
  • 资助金额:
    $ 30.8万
  • 项目类别:
Developing resources to alleviate muscle atrophy in FSHD by genome engineering
通过基因组工程开发资源缓解 FSHD 肌肉萎缩
  • 批准号:
    8532067
  • 财政年份:
    2012
  • 资助金额:
    $ 30.8万
  • 项目类别:
Heterochromatin on the human inactive X chromosome
人类失活 X 染色体上的异染色质
  • 批准号:
    7008484
  • 财政年份:
    2005
  • 资助金额:
    $ 30.8万
  • 项目类别:
Heterochromatin on the human inactive X chromosome
人类失活 X 染色体上的异染色质
  • 批准号:
    7172232
  • 财政年份:
    2005
  • 资助金额:
    $ 30.8万
  • 项目类别:
Heterochromatin on the human inactive X chromosome
人类失活 X 染色体上的异染色质
  • 批准号:
    6862191
  • 财政年份:
    2005
  • 资助金额:
    $ 30.8万
  • 项目类别:
Heterochromatin on the human inactive X chromosome
人类失活 X 染色体上的异染色质
  • 批准号:
    8512916
  • 财政年份:
    2005
  • 资助金额:
    $ 30.8万
  • 项目类别:
Heterochromatin on the human inactive X chromosome
人类失活 X 染色体上的异染色质
  • 批准号:
    7342441
  • 财政年份:
    2005
  • 资助金额:
    $ 30.8万
  • 项目类别:
Heterochromatin on the human inactive X chromosome
人类失活 X 染色体上的异染色质
  • 批准号:
    8327212
  • 财政年份:
    2005
  • 资助金额:
    $ 30.8万
  • 项目类别:
Heterochromatin on the human inactive X chromosome
人类失活 X 染色体上的异染色质
  • 批准号:
    7921683
  • 财政年份:
    2005
  • 资助金额:
    $ 30.8万
  • 项目类别:

相似国自然基金

帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 批准年份:
    2021
  • 资助金额:
    58.00 万元
  • 项目类别:
    面上项目
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    58 万元
  • 项目类别:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
  • 批准号:
    31672538
  • 批准年份:
    2016
  • 资助金额:
    62.0 万元
  • 项目类别:
    面上项目
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 批准年份:
    2013
  • 资助金额:
    80.0 万元
  • 项目类别:
    面上项目
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
  • 批准号:
    81172529
  • 批准年份:
    2011
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
  • 批准号:
    81070952
  • 批准年份:
    2010
  • 资助金额:
    35.0 万元
  • 项目类别:
    面上项目
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
  • 批准号:
    30672361
  • 批准年份:
    2006
  • 资助金额:
    24.0 万元
  • 项目类别:
    面上项目

相似海外基金

Bridging the Gap: Next-Gen Tools for Accurate Prediction of Disordered Protein Binding Sites
弥合差距:准确预测无序蛋白质结合位点的下一代工具
  • 批准号:
    24K15172
  • 财政年份:
    2024
  • 资助金额:
    $ 30.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Design of protein crystal templates with multiple binding sites for tracking metal complex reactions.
设计具有多个结合位点的蛋白质晶体模板,用于跟踪金属络合物反应。
  • 批准号:
    23K04928
  • 财政年份:
    2023
  • 资助金额:
    $ 30.8万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Dynamic changes in PIP2 binding sites and their impact on axonal targeting and function of epilepsy-associated KCNQ/Kv7 channels
PIP2 结合位点的动态变化及其对癫痫相关 KCNQ/Kv7 通道的轴突靶向和功能的影响
  • 批准号:
    10744934
  • 财政年份:
    2023
  • 资助金额:
    $ 30.8万
  • 项目类别:
Computational methods to identify small molecule RNA binding sites
识别小分子 RNA 结合位点的计算方法
  • 批准号:
    573688-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 30.8万
  • 项目类别:
    University Undergraduate Student Research Awards
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
  • 批准号:
    10704557
  • 财政年份:
    2022
  • 资助金额:
    $ 30.8万
  • 项目类别:
Identification of potential drug binding sites within allosteric networks in cyclic nucleotide modulated channels
环核苷酸调节通道变构网络内潜在药物结合位点的鉴定
  • 批准号:
    10537846
  • 财政年份:
    2022
  • 资助金额:
    $ 30.8万
  • 项目类别:
Identifying new types of inhibitors in quinone binding sites in photosynthetic enzymes
鉴定光合酶醌结合位点的新型抑制剂
  • 批准号:
    2753921
  • 财政年份:
    2022
  • 资助金额:
    $ 30.8万
  • 项目类别:
    Studentship
Development of broad nanovaccines targeting diverse coronavirus receptor-binding sites
开发针对不同冠状病毒受体结合位点的广泛纳米疫苗
  • 批准号:
    10328140
  • 财政年份:
    2022
  • 资助金额:
    $ 30.8万
  • 项目类别:
Exploiting Water Network Perturbations in Protein Binding Sites
利用蛋白质结合位点的水网络扰动
  • 批准号:
    10621368
  • 财政年份:
    2021
  • 资助金额:
    $ 30.8万
  • 项目类别:
SBIR Phase I: Nonlinear optical method for identifying protein-ligand binding sites
SBIR 第一阶段:识别蛋白质-配体结合位点的非线性光学方法
  • 批准号:
    2111821
  • 财政年份:
    2021
  • 资助金额:
    $ 30.8万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了